http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0128522-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-088
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
filingDate 1984-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1989-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0128522-B1
titleOfInvention High titer cytomegalovirus human immune serum globulin and method of making same
abstract Normal plasma from donors who have not been vaccinated with a cytomegalovirus vaccine can be screened for higher than normal titers of naturally occurring antibody to cytomegalovirus. Those plasmas with high titers of such antibody can be pooled and fractionated to give hyperimmune serum globulin. The product may be treated to render it suitable for intravenous injection. Patients with cytomegalovirus infection or at risk to such infection, may receive the present product to raise serum titers of cytomegalovirus antibody.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9149524-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9491906-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9371372-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9127049-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603480-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9803000-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8298538-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9217028-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309089-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9725502-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8765132-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9249213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8298539-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9221897-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9365636-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8287870-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10889632-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10040845-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8545848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9611316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9796772-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9796771-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8435524-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9527902-B2
priorityDate 1983-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4686862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439186

Total number of triples: 49.